[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  TENET RESEARCH [@tenet_research](/creator/twitter/tenet_research) on x 452.5K followers Created: 2025-07-17 19:45:55 UTC $CANTA - Cantargia Announces Preliminary Topline Efficacy Results From the Phase X TRIFOUR Trial of Nadunolimab in Advanced Triple-Negative Breast Cancer (TNBC) XXXXX engagements  **Related Topics** [$canta](/topic/$canta) [Post Link](https://x.com/tenet_research/status/1945932999691771926)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TENET RESEARCH @tenet_research on x 452.5K followers
Created: 2025-07-17 19:45:55 UTC
$CANTA - Cantargia Announces Preliminary Topline Efficacy Results From the Phase X TRIFOUR Trial of Nadunolimab in Advanced Triple-Negative Breast Cancer (TNBC)
XXXXX engagements
Related Topics $canta
/post/tweet::1945932999691771926